If successful, this could significantly improve compliance and expand access In February 2024, Amgen Inc
Metabolic Support: Beyond weight loss, the compound is being evaluated for its ability to regulate blood sugar and improve overall metabolic markers
2020;8(2):e001706
The GLP-1 component reduces food intake, the GIP component improves nutrient partitioning, and the glucagon component increases fat burning
They cannot make medical claims and have not undergone the same rigorous testing as prescription medications
The most common side effects of semaglutide, including symptoms of low blood sugar such as nausea, vomiting, diarrhea, constipation, and abdominal pain, usually get better with time as your body gets used to the medicine